ONCOPIG CANCER MODEL- oncopig not applicable 
Sus Clinicals, Inc

----------

Oncopig Cancer Model

Cre-inducible Neo-KRASG12D-TP53R167H rDNA construct in the ITPRID1 gene in cross-bred swine

This is an investigational animal that contains intentional genomic alterations. This animal and any products derived from it are for research purposes only and not for use in humans or as food/feed unless authorization has been granted by the US Food and Drug Administration.FDA package labelFDA package labelFDA package label

ONCOPIG CANCER MODEL 
oncopig not applicable
Product Information
Product TypeRECOMBINANT DEOXYRIBONUCLEIC ACID CONSTRUCT LABELItem Code (Source)NDC:86150-0001
Route of AdministrationNOT APPLICABLE
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Cre-inducible Neo-KRASG12D-TP53R167H rDNA construct in the ITPRID1 gene in cross-bred swine (UNII: MT2ELV39H4) (Cre-inducible Neo-KRASG12D-TP53R167H rDNA construct in the ITPRID1 gene in cross-bred swine - UNII:MT2ELV39H4) Cre-inducible Neo-KRASG12D-TP53R167H rDNA construct in the ITPRID1 gene in cross-bred swine1 [arb'U]  in 1 [arb'U]
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:86150-0001-11 [arb'U] in 1 NOT APPLICABLE
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other12/09/2021
Labeler - Sus Clinicals, Inc (117539542)
Registrant - Sus Clinicals, Inc (117539542)
Establishment
NameAddressID/FEIBusiness Operations
University of Illinois Comparative Genomics Laboratory118385427manufacture

Revised: 12/2021
Document Id: 14991b46-9a2f-462f-bdc0-9ac31fd2c3ee
Set id: d746eddb-a964-464b-b3fe-b90b34f2d5a3
Version: 2
Effective Time: 20211217
 
Sus Clinicals, Inc